06/10/2026
Topical steroids have been the default for pediatric atopic dermatitis (AD) for decades. But with growing concern around topical steroid withdrawal and a new generation of nonsteroidal options reaching the clinic, the conversation is shifting fast.
That's the focus of ‘Targeted Topical Innovations For Your Pediatric Patients’ at Pediatrics360, where Linda F. Stein Gold, MD, and Elizabeth (Lisa) A. Swanson, MD, join moderator Lawrence Eichenfield, MD, to walk through what the latest data says about emerging nonsteroidal topicals in pediatric patients, and how to put it to work in your practice. The session also includes a live Q&A where you can propose your toughest cases to the faculty directly.
June 13, 2026 | 11:05 AM EDT
Earn up to 0.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™ for this session, and up to 4.5 CME credits for Parts 1 and 2 of this virtual conference.
Not registered yet? Sign up for Pediatrics360 for FREE at: https://dermsquared.org/conferences/pediatrics360-2026/overview
This activity is supported by educational grants from Arcutis Biotherapeutics, Inc., Incyte and Organon.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education (“Institute”) and CMEsquared®. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
The Institute for Continuing Healthcare Education designates this live conference activity for a maximum of 4.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.